{"title":"Outcome Factors for Women Undergoing Transcatheter Aortic Valve Replacement","authors":"Muhammad Asim Shabbir MD , Natalia Berry MD , Emily Perdoncin MD , Poonam Velagapudi MS, MD","doi":"10.1016/j.iccl.2024.08.009","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38721,"journal":{"name":"Interventional Cardiology Clinics","volume":"14 1","pages":"Pages 117-125"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Cardiology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211745824000919","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
接受经导管主动脉瓣置换术的女性的结果因素。
患有严重主动脉瓣狭窄并接受经导管主动脉瓣置换术(TAVR)的女性患者症状较重,在接受 TAVR 手术时年龄较大,而且其独特的解剖特征增加了围手术期的风险。不过,与男性相比,女性的长期预后(包括死亡率)较好。在考虑血管通路和选择瓣膜平台时,需要谨慎小心,以减少并发症。需要专门针对接受 TAVR 的女性进行大型前瞻性试验,以研究决定疗效的女性特异性因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。